[1]
T. Mesti, M. Ebert Moltara, M. Boc, M. Reberšek, and J. Ocvirk, “Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience”, Radiol Oncol, vol. 49, no. 1, Feb. 2015.